TP53 and neoplasm: The approach that we are taking in this regard combines ICI with gene therapy that restores the functions of the tumor suppressor p53 via SGT-53, an investigational tumor-targeting nanomedicine comprising a novel cationic immunoliposome encapsulating a plasmid DNA carrying the wild-type TP53 gene.